PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2011.43.2.75201143275-82The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing ParadigmsMax Dahele, Suresh Senanhttp://www.e-crt.org/upload/pdf/crt-43-75.pdf, http://www.e-crt.org/upload/pdf/crt-43-75.pdf
Lung Cancer10.1016/j.lungcan.2015.11.01520169222-28The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancerEduardo Guerrero, Merina Ahmedhttps://api.elsevier.com/content/article/PII:S0169500215301112?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500215301112?httpAccept=text/plain
Cancer10.1002/cncr.2969820151222322-323Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancerAlexander V. Louie, Shankar Siva, Suresh Senanhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.29698, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29698/fullpdf
Cancer10.1002/cncr.2969920151222323-324Reply to defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancerHiran C. Fernando, Damian E. Dupuyhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.29699, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29699/fullpdf
Radiotherapy and Oncology10.1016/j.radonc.2014.11.03620151142138-147Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: Controversies, insights, and changing horizonsAlexander V. Louie, David A. Palma, Max Dahele, George B. Rodrigues, Suresh Senanhttps://api.elsevier.com/content/article/PII:S0167814014005416?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0167814014005416?httpAccept=text/plain
Clinical Lung Cancer10.1016/j.cllc.2012.06.00520131411-5Improving Outcomes for High-Risk Patients With Early-Stage Non–Small-Cell Lung Cancer: Insights from Population-Based Data and the Role of Stereotactic Ablative RadiotherapyDavid A. Palma, Suresh Senanhttps://api.elsevier.com/content/article/PII:S1525730412001362?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730412001362?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(13)70171-5201379S58171 Stereotactic ablative radiotherapy (SABR) in medically inoperable early stage non-small cell lung cancer (NSCLC): A single tertiary UK centre experienceC. Yip, D.B. Landau, C. Thomas, S. Ahmadhttps://api.elsevier.com/content/article/PII:S0169500213701715?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500213701715?httpAccept=text/plain
Lung Cancer10.1016/j.lungcan.2012.05.016201277S9-S10Stereotactic body radiotherapy for early stage non-small cell lung cancerF. Lagerwaardhttps://api.elsevier.com/content/article/PII:S0169500212002334?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500212002334?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(20)30243-92020139S91SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC): a randomised phase III trialF. McDonald, K.M. Mak, J. Teague, D. Landau, G. Hanna, L. Farrelly, N. Counsellhttps://api.elsevier.com/content/article/PII:S0169500220302439?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500220302439?httpAccept=text/plain
Early-stage Lung Cancer10.1007/978-981-10-7596-4_122018237-261Management Strategies for Early-Stage Lung Cancer: Stereotactic Ablative RadiotherapyXiangpeng Zheng, Yanping Ren, Yuxin Jiaohttp://link.springer.com/content/pdf/10.1007/978-981-10-7596-4_12